[研究报告] 近距离放射治疗设备市场预计将从 2022 年的 3.1096 亿美元增长到 2030 年的 5.0175 亿美元;预计 2022 年至 2030 年的复合年增长率为 6.2%。
分析师观点
近距离放射治疗,也称为内部放射治疗 (IRT),涉及在肿瘤附近插入放射性装置,例如种子、带、线、针、胶囊、气球或管子,以提供高剂量的辐射。这种治疗可有效消除和缩小肿瘤。近距离放射治疗不同于其他形式的放射治疗,因为它允许施用更高剂量的辐射,同时最大限度地减少对周围器官的损害。癌症患病率的上升是促进近距离放射治疗设备市场增长的主要因素。此外,技术进步和 IRT 在癌症管理中的采用率上升也促进了市场增长。然而,近距离放射治疗相关的风险和缺乏熟练的技术人员阻碍了市场增长。
市场洞察
乳腺癌、前列腺癌和宫颈癌等癌症的发病率不断上升,推动了近距离放射治疗设备市场规模的增长。根据世界卫生组织 (WHO) 于 2024 年 2 月发布的统计数据,2022 年全球报告的癌症新病例约为 2000 万例,死亡人数为 970 万例。在这些病例中,乳腺癌是最常见的癌症类型,女性确诊病例为 230 万例。此外,前列腺癌和结直肠癌是男性中第二和第三大常见癌症。近距离放射治疗设备通常用于有效治疗妇科、前列腺、乳腺癌和其他类型的癌症。这些设备包括植入肿瘤附近的充满放射性物质的导线、种子或棒,通过发射特定距离的辐射来治疗肿瘤。
此外,与其他放射疗法相比,近距离放射治疗耗时更少,副作用也更少。根据爱思唯尔 2023 年 6 月发表的一篇文章,该研究旨在通过收集大型多机构数据库来比较近距离放射治疗与外束放射治疗(EBRT) 的结果,得出的结论是,与 EBRT 相比,使用近距离放射治疗设备与提高生存率和降低远处癌症转移发生率有关。这一发现意义重大,可以鼓励采用近距离放射治疗作为中高风险前列腺癌患者的一种经济有效的治疗选择。
因此,随着全球癌症发病率持续上升,近距离放射治疗作为一种广泛使用的治疗选择的需求对促进近距离放射治疗设备市场的增长做出了重要贡献。brachytherapy as a widely accessible treatment option contributes significantly to boosting brachytherapy devices market growth.
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围
“近距离放射治疗设备市场分析”是通过考虑以下几个部分来进行的:产品类型、类型、应用和最终用户。
根据产品类型,市场分为种子、近距离放射治疗后装器和施放器以及电子近距离放射治疗。根据类型,市场分为高剂量率近距离放射治疗植入物和低剂量率近距离放射治疗植入物。根据应用,市场分为乳腺癌、宫颈癌、前列腺癌、肺癌等。
根据最终用户,市场分为医院和专科诊所、门诊手术中心和其他。
全球近距离放射治疗设备市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
基于产品类型的洞察
根据产品类型,近距离放射治疗设备市场细分为种子、近距离放射治疗后装器和施用器以及电子近距离放射治疗。近距离放射治疗后装器和施用器细分市场在 2022 年占据最大市场份额,预计在 2022-2030 年期间将实现最高复合年增长率。
基于类型的洞察
按类型划分,市场分为高剂量近距离放射治疗植入物和低剂量率近距离放射治疗植入物。低剂量率近距离放射治疗植入物部分在 2022 年占据了较大的近距离放射治疗设备市场份额,预计 2022 年至 2030 年的复合年增长率将更快。
基于应用的洞察
近距离放射治疗设备市场按应用细分为乳腺癌、宫颈癌、前列腺癌、肺癌等。前列腺癌领域在 2022 年占据最大市场份额,预计在 2022-2030 年期间将实现最高复合年增长率。
基于最终用户的洞察
根据最终用户,市场细分为医院和专科诊所、门诊手术中心和其他。医院部门在 2022 年占据了最大的市场份额。这可以归因于医院比其他外科中心拥有更好的设施和熟练的医生来执行微创手术。
区域分析
根据地域,市场分为北美、亚太地区、欧洲、中东和非洲以及南美和中美洲。就收入而言,北美在 2022 年占据了近距离放射治疗设备市场份额的主导地位。该地区的近距离放射治疗设备市场由美国主导。这可以归因于多种因素,包括该地区女性乳腺癌和男性前列腺癌病例的增加。根据泛美卫生组织 (PAHO) 的数据,2020 年,美洲估计有 400 万人被诊断出患有癌症,预计到 2040 年将增加约 60%。
此外,包括 BD、Isoray Inc. 和 Elekta 在内的市场参与者的存在以及先进近距离放射治疗设备的可用性为市场扩张提供了巨大的机会。例如,2021 年 7 月,GenesisCare 通过从 Elekta 采购 27 个 Flexitron 近距离放射治疗后装系统和服务协议,扩展了其近距离放射治疗服务。这些先进的癌症治疗设备使 GenesisCare 能够跟上最新技术,并为其在美国各地的中心的患者提供高质量的护理。
近距离放射治疗设备市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响近距离放射治疗设备市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的近距离放射治疗设备市场细分和地理位置。
- 获取近距离放射治疗设备市场的区域特定数据
近距离放射治疗设备市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 3.1096亿美元 |
2030 年市场规模 | 5.0175亿美元 |
全球复合年增长率(2022 - 2030 年) | 6.2% |
史料 | 2020-2022 |
预测期 | 2022-2030 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
近距离放射治疗设备市场参与者密度:了解其对业务动态的影响
近距离放射治疗设备市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明相对于给定市场空间的规模或总市场价值,有多少竞争对手(市场参与者)存在于该市场空间中。
在近距离放射治疗设备市场运营的主要公司有:
- 医科达
- 瓦里安医疗系统公司
- BEBIG医疗
- 泰瑞金公司
- 同种援助
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解近距离放射治疗设备市场的主要参与者概况
行业发展和未来机遇:
近距离放射治疗设备市场预测可以帮助该市场的利益相关者制定增长战略。根据公司新闻稿,以下列出了全球市场领先企业的一些战略发展:
- 2023 年 10 月,Elekta 宣布通过资产收购从 iCAD, Inc. 手中收购 Xoft 业务。通过收购 Xoft Axxent 电子近距离放射治疗 (eBx) 系统以及员工转移,该公司旨在提供更广泛的癌症治疗选择和电子近距离放射治疗技术。
- 根据 2023 年 7 月的新闻稿,CIVCO 放射治疗中心在 2022 年 10 月 23 日至 26 日在德克萨斯州圣安东尼奥举行的美国放射肿瘤学会 (ASTRO) 年会上宣布与提供患者定位和固定设备的公司 Qfix 建立合作伙伴关系。
- 2022 年 7 月,BEBIG Medical 收购了 Wolf-Medizintechnik GmbH (WOmed),这是一家向全球市场供应尖端 X 射线治疗和新开发的术中放射治疗产品的德国公司。此次收购旨在扩大 BEBIG Medical 在癌症放射治疗方面的产品组合。
- 2020 年 12 月,瓦里安医疗系统公司推出了四套新型近距离放射治疗施放器,用于阴道、宫颈、子宫、子宫内膜和直肠的 HDR 近距离放射治疗。这套新型施放器旨在解决施放器尺寸、易用性和 MRI 成像支持等问题。这一新产品让患者使用起来更加方便,也更加舒适,让临床医生能够在门诊治疗更多患者。
Elekta、Varian Medical Systems, Inc.、BEBIG Medical、Theragenics Corporation、IsoAid、Siemens Healthineers AG、BXTA、BD、Eckert and Ziegler 和 Perspective Therapeutics 是近距离放射治疗设备市场报告中介绍的一些主要公司。这些领先企业专注于扩大和多样化其市场影响力和客户群,挖掘市场中的商机。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The brachytherapy therapy devices market, by application, is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The brachytherapy therapy devices market, by product type, is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders and applicators segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The brachytherapy therapy devices market is expected to be valued at US$ 501.75 million in 2030.
The brachytherapy therapy devices market was valued at US$ 310.96 million in 2022.
Key factors driving the brachytherapy therapy devices market growth include the growing prevalence of cancer, and technological advancements.
The brachytherapy therapy devices market majorly consists of the players such as Elekta; Varian Medical Systems, Inc.; BEBIG Medical; Theragenics Corporation; IsoAid; Siemens Healthineers AG; BXTA; BD; Eckert and Ziegler; and Perspective Therapeutics.
Brachytherapy devices such as seeds, ribbons, wires, needles, capsules, balloons, or tubes are used either inside the target volume or near the tumors to deliver high doses of radiation for the treatment of cancer and other benign disorders. Depending on the duration of radioactive sources left in place, brachytherapy can be provided by either high-dose rate (HDR) or low-dose rate (LDR) procedures.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Brachytherapy Devices Market
- Elekta
- Varian Medical Systems, Inc.
- BEBIG Medical
- Theragenics Corporation
- IsoAid
- Siemens Healthineers AG
- BXTA
- BD
- Eckert and Ziegler
- Perspective Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.